Ellis Investment Partners, LLC - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ellis Investment Partners, LLC ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2022$2,000
-71.4%
1500.0%0.00%
-50.0%
Q2 2022$7,000
-36.4%
1500.0%0.00%
-33.3%
Q1 2022$11,000
-47.6%
1500.0%0.00%
-40.0%
Q4 2021$21,000
+5.0%
150
+50.0%
0.01%0.0%
Q3 2021$20,000
-4.8%
1000.0%0.01%0.0%
Q2 2021$21,000
+16.7%
1000.0%0.01%0.0%
Q1 2021$18,000
+63.6%
1000.0%0.01%
+66.7%
Q4 2020$11,0001000.00%
Other shareholders
NOVAVAX INC shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 2,559,918$543,496,0008.72%
Foresite Capital Management I, LLC 66,810$14,184,0008.55%
Samsara BioCapital, LLC 198,600$42,165,0005.20%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 330,541$70,177,0004.54%
Foresite Capital Management II, LLC 67,373$14,304,0003.85%
Rock Springs Capital Management LP 455,000$96,601,0001.91%
DELTEC ASSET MANAGEMENT LLC 56,320$11,957,0001.65%
Parametrica Management Ltd 10,200$2,166,0001.60%
SECTORAL ASSET MANAGEMENT INC 88,450$18,779,0001.52%
TSP Capital Management Group, LLC 18,525$3,933,0001.29%
View complete list of NOVAVAX INC shareholders